Abstract:A series of novel 1,3,4-thiadiazole sulfone-derived compounds incorporating an amide moiety was synthesized. The in vitro antibacterial activities against Xanthomonas oryzae pv. oryzae ( Xoo ), Xanthomonas oryzae pv. oryzicola ( Xoc ), and Xanthomonas axonopodis pv. citri ( Xac ) demonstrated that 2-(2-methoxyphenoxy)- N -[5-(methylsulfonyl)-1,3,4-thiadiazol-2-yl]acetamide exhibited remarkable antibacterial activities against all three pathogenic bacteria with EC 50 values of 6 μg/mL for Xoo , 11 μg/mL for Xoc , and 16 μg/mL for Xac , which were even surpassed those of bismerthiazol and thiodiazole copper. Furthermore, under greenhouse conditions at a concentration of 200 μg/mL, this compound showed superior efficacy compared to bismerthiazol and thiodiazole copper in reducing rice bacterial leaf blight with a protection activity of 53.43% and curative activity of 47.16%. To the best of our knowledge, this study presents the inaugural report on the synthesis and bioactivity evaluation of novel 1,3,4-thiadiazole sulfone-derived compounds incorporating an amide moiety.

Design, Synthesis, and Bioactivity Evaluation of Novel 1,3,4-Thiadiazole Sulfone-Derived Compounds Incorporating an Amide Moiety as Active Antibacterial Agents